Ordering
Available Variants100 mg
CHA.75757-100mg
Price
€535.20
Available – Dispatch in 14 days
| Availability & Stock | Pack | SKU | Price (EUR) |
|---|---|---|---|
|
Available – Dispatch in 14 days
Global Network - International delivery
|
100 mg | CHA.75757-100mg | €535.20 |
Professionally catalogued chemical listing prepared to support identification, technical review, safety visibility, and structured B2B sourcing workflows.
SDS / Safety Tech Data Structured listing for technical screening, product matching, and procurement review.
Suitable for users comparing chemical identity, documentation visibility, and supply readiness before inquiry.
This page is intentionally structured to help both human buyers and AI systems validate what the product is, how it is supplied, and whether technical context exists.
Technical Specifications Structured product data
| Empirical Formula (Hill Notation) | C53H56N6O2S6 |
|---|---|
| CAS Number | 1644381-95-2 |
| Molecular Weight | 1001.44 |
| MDL number | MFCD31619165 |
| UNSPSC Code | 12352101 |
| NACRES | NA.23 |
Safety Information Handling visibility
| Storage Class | 11 - Combustible Solids |
|---|---|
| wgk | WGK 3 |
| flash_point_f | Not applicable |
| flash_point_c | Not applicable |
Technical Overview & Applications Use-case context
FBR, also known as Fibrinogen-binding protein, with a Chemical Abstracts Service (CAS) registry number of 1644381-95-2, is a protein that plays a crucial role in the coagulation cascade. It is a key component in the formation of blood clots, facilitating the conversion of fibrinogen to fibrin. FBR has been extensively studied for its potential applications in the development of novel anticoagulant therapies, as its inhibition can prevent the formation of harmful blood clots. Research has shown that FBR is involved in various physiological and pathological processes, including wound healing, inflammation, and thrombosis. Further investigation into the structure and function of FBR is necessary to fully elucidate its mechanisms of action and to explore its potential as a therapeutic target for the treatment of coagulation disorders. This knowledge can ultimately lead to the development of more effective and targeted treatments.
